Erratum: A history of AIDS: Looking back to see ahead (European Journal of Immunology (2007) vol. 37 (S1) 10.1002/eji.200737441);A history of AIDS: Looking back to see ahead

European Journal of Immunology

Volumn 37, Issue SUPPL. 1, 2007, Pages 309-

  Greene, Warner C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Drug design discovery; Global pandemic; HIV; Infectious diseases

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRASE; INTEGRASE INHIBITOR; LAMIVUDINE; MARAVIROC; NEVIRAPINE; NONOXINOL 9; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ARTICLE; BLOOD TRANSFUSION; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; ENDOCRINE DISEASE; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH PROGRAM; HEMATOLOGIC DISEASE; HEMOPHILIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; LIPODYSTROPHY; MULTIDRUG RESISTANCE; NONHUMAN; OPPORTUNISTIC INFECTION; PANDEMIC; PREGNANT WOMAN; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; T CELL DEPLETION; VERTICAL TRANSMISSION; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 36249031973     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200790063     Document Type: Erratum

References (46)

1. NAIDS/WHO, AIDS Epidemic Update December 2006.
2. Morbidity & Mortality Weekly Report. Kaposi's sarcoma and pneumocystis pneumonia among homosexual men - New York City and California. MMWR Weekly 1981. 30: 305-308.
3. Morbidity & Mortality Weekly Report. Epidemiologic notes and reports: possible transfusion-associated acquired immune deficiency syndrome, AIDS - California. MMWR Weekly 1982. 31: 652-654.
4. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. and Gallo, R. C., Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980. 77: 7415-7419.
5. Uchiyama, T., Yodoi, J., Sagawa, K, Takatsuki, K. and Uchino, H., Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977. 50: 481-492.
6. Morbidity & Mortality Weekly Report. Epidemiologic notes and reports: immunodeficiency among female sexual partners of males with acquired immune deficiency syndrome (AIDS) - New York. MMWR Weekly 1983. 31: 697-698.
7. Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C. et al., isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983. 220: 868-871.
8. Gallo, R. C., Salabuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J. et al., Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984. 224: 500-503.
9. Popovic, M., Sarngadharan, M. G., Read, E. and Gallo, R. C., Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS arid pre-AIDS. Science 1984. 224: 497-500.
10. Schupbach, J., Popovic, M., Gilden, R. V., Gonda, M. A., Sarngadharan, M. G. and Gallo, R. C., Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science 1984. 224: 503-505.
11. Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M. and Oshiro, L. S., Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 1984. 225: 840-842.
12. Coffin, J., Haase, A., Levy, J. A., Montagnier, L., Oroszlan, S., Teich, N., Temin, H. et al., What to call the AIDS virus? Nature 1986. 321: 10.
13. Safai, B., Sarngadharan, M. G., Groopman, J. E., Arnett, K., Popovic, M., Sliski, A., Schupbach, J. and Gallo, R. C., Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet 1984. 1: 1438-1440.
14. Sarngadharan, M. G., Popovic, M., Bruch, L., Schupbach, J. and Gallo, R. C., Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984. 224: 506-508.
15. Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R. et al., Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985. 313: 277-284.
16. Sanchez-Pescador, R., Power, M. D., Barr, P. J., Steimer, K. S., Stempien, M. M., Brown-Shimer, S. L. et al., Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 1985. 227: 484-492.
17. Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S. and Alizon, M., Nucleotide sequence of the AIDS virus, LAV. Cell 1985. 40: 9-17.
18. Hahn, B. H., Gonda, M. A., Shaw, G. M., Popovic, M., Hoxie, J. A., Gallo, R. C. and Wong-Staal, F., Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc. Natl. Acad. Sci. USA 1985. 82: 4813-4817.
19. Wong-Staal, F., Shaw, G. M., Hahn, B. H., Salahuddin, S. Z., Popovic, M., Markham, P., Redfield, R. and Gallo, R. C., Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science 1985. 229: 759-762.
20. Dalgleish, A. G., Beverley, P. C., Clapham, P. R., Crawford, D. H., Greaves, M. F. and Weiss, R. A., The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984. 312: 763-767.
21. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J. C. and Montagnier, L., T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984. 312: 767-768.
22. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P. et al., Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996. 381: 661-666.
23. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996. 381: 667-673.
24. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996. 272: 872-877.
25. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E. et al., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996. 86: 367-377.
26. Ray, N. and Doms, R. W., HIV-1 coreceptors and their inhibitors. Curr. Top. Microbiol. Immunol. 2006. 303: 97-120.
27. Greene, W. C. and Peterlin, B. M., Charting HIVs remarkable voyage through the cell: Basic science as a passport to future therapy. Nat. Med. 2002. 8: 673-680.
28. Schroder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R. and Bushman, F., HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002. 110: 521-529.
29. Egbertson, M. S., Moritz, H. M., Melamed, J. Y., Han, W., Perlow, D. S., Kuo, M. S., Embrey, M. et al., A potent and orally active HIV-1 integrase inhibitor. Bioorg. Med. Chem. Lett. 2007. 17: 1392-1398.
30. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. and Desrosiers, R. C., Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991. 65: 651-662.
31. Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A. et al., Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001. 107: 55-65.
32. Serwadda, D., Mugerwa, R. D., Sewankambo, N. K., Lwegaba, A., Carswell, J. W., Kirya, G. B., Bayley, A. C. et al., Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985. 2: 849-852.
33. Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M. J., VanDyke, R. et al., Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group. N. Engl. J. Med. 1994. 331: 1173-1180.
34. Cooper, D.A. and Merigan, T. C., Clinical treatment. Aids 1996. 10 Suppl A: S133-S134.
35. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. and Markowitz, M., Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995. 373: 123-126.
36. Blankson, J. N., Persaud, D. and Siliciano, R. F., The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 2002. 53: 557-593.
37. Flynn, N. M., Forthal, D. N., Harro, C. D., Judson, F. N., Mayer, K. H. and Para, M. F., Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis. 2005. 191: 654-665.
38. Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D. et al., Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HTV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 2006. 194: 1661-1671.
39. VandeWoude, S. and Apetrei, C., Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin. Microbiol. Rev. 2006. 19: 728-762.
40. Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R. et al., Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 1999. 179: 859-870.
41. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z. et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006. 12: 1365-1371.
42. + T cell depletion and viral replication in SIV infection. Science 1998. 280: 427-431.
43. Sheehy, A. M., Gaddis, N. C., Choi, J. D. and Malim, M. H., Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002. 418: 646-650.
44. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. and Sodroski, J., The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004. 427: 848-853.
45. Newell, M. L. and Barnighausen, T., Male circumcision to cut HIV risk in the general population. Lancet 2007. 369: 617-619.
46. Grant, R. M., Buchbinder, S., Cates, W., Jr., Clarke, E., Coates, T., Cohen, M. S., Delaney, M. et al., AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science 2005. 309: 2170-2171.